Our partner is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs in hypercortisolism. To support this mission, they collaborate with numerous scientists and clinical researchers to find better ways to improve patient lives. We all have unique contributions to make, and their success is the sum of those contributions.
Through explosive growth over the last 12 months, the clinical team is continuing to expand. With multiple studies running, the team will be adding up to 3 more in the next 8-10 months. With 5 compounds (combo therapies) and additional studies upcoming, this is an environment that will flourish on your strategy and design experience.
This highly visible Senior Medical Director will walk into an environment that brings exudes exciting science and provides multiple programs. Not only will you be involved in early and late phase studies, you have the opportunity to roll up your shirt sleeves and simply shine. In addition to their current pipeline, they are also kicking off another niche Checkpoint Inhibitor study!
With 1 approved drug, 8 Phase II trials, and MultiplePhase III trials our partner is blazing the trail for success.The reason why, patients come first. They develop medications that meet medical needs. No patient is denied a medication for financial reasons. Everyone on their team has the same goal; developing safe and effective medical therapies for patients who need them.
Through their collaborations with researchers around the world, more than 30 studies are underway to investigate the treatment of serious and life-threatening diseases driven by their vision.
As the Senior Medical Director, your efforts, passion, and dedication will be visible throughout the organization. With your energy, ideas, and vision…you will be able to contribute to critical life changing medicine versus simply checking the boxes.
Reporting into the VP of Clinical Development, Oncology you will work on strategy and tactical deliverables.
Clinical Development Objectives:
-Lead multiple studies and/or program in oncology (Solid Tumor).
-Someone who is excited to take on new challenges in a fast-paced and dynamic start-up environment.
-Willing to lead, but from a confidence perspective….to help create an environment for continued success.
-Support development of trial-related documents and processes.
-Define clinical study protocols; recommend new clinical trial sites and investigators; recommend specific data outputs and publications.
-Support regulatory activities, medical affairs, and payer engagements; represent our partner in external scientific and medical forums.
-Provide medical support for pharmacovigilance activities.
-Actively observe and adopt relevant new medical trends/tools in specific therapeutic areas.
-Establish and/or maintain contacts with external collaborators, e.g., key opinion leaders, in specific therapeutic areas.
-Serve as a medical spokesperson for the company, as needed, with the internal and external community including various regulatory and governmental agencies.
-Assure medical/scientific integrity of clinical trials related to a therapeutic program.
-Provide training and ongoing input to colleagues on medical issues related to therapeutic field in question.
-Assess and interpret trial results.
-Provide medical support to investigative sites and project staff for protocol-related issues including protocol clarifications, inclusion/exclusion determinations, and issues of patient safety and/or eligibility.
-Medical degree required with a minimum of 5 years of practical experience.
-Significant oncology and Board Certification highly preferred.
-Ability for strategic and proactive thinking, strong scientific and analytical skills, decisiveness and the ability to perform as a respected team member and leader.
-High integrity, “get-it-done”, “roll-up-your-sleeves” attitude and committed to putting patients first.
-Located in the Redwood City, CA area.
-Our partner prides itself on a dynamic culture which remains true to its values while embracing continued growth and change.
-Their work is marked by innovation, integrity, rigor, transparent communication, and collaboration.
-Well diversified clinical stage company with wholly owned assets and partnered products – not a single asset company.
-Pipeline consists of 3 compounds in development with multiple therapeutic areas that include (Oncology, Endocrinology /Metabolic, Ophthalmology) and several indications within each program. Utilizing Glucocorticoid Receptor Antagonism and Checkpoint Inhibitor platforms, along with multiple combo therapies, the platform for success is well established.
Corporate Facts & Objectives:
-Our partner prides itself on a dynamic culture which remains true to its values while embracing continued growth and change. Their work is marked by innovation, integrity, rigor, transparent communication, and collaboration. We all have unique contributions to make, and their success is the sum of those contributions.
-Supporting patients and advancing science form the foundation of our culture. To meet their ambitious goals, they foster a diverse and collaborative environment that values each of their employees and their unique contributions.
-205 employees with continued projected growth over 2020.
-1 commercial product with numerous existing trials and 18 new studies planned.Strong collaborations to advance the pre-clinical and clinical development programs.